Market Tracker

02/22 3:04am ET

Celgene Corp (NASDAQ:CELG)

119.44
Delayed Data
As of Feb 21
 -1.72 / -1.42%
Today’s Change
94.39
Today|||52-Week Range
127.00
+3.19%
Year-to-Date

Today’s Trading

Previous close121.16
Today’s open121.39
Day’s range119.12 - 122.22
Volume4,641,754
Average volume (3 months)4,671,971
Market cap$94.3B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+21.56%
Earnings growth (next 5 years)+22.37%
Revenue growth (last year)+22.70%
P/E ratio48.0
Price/Sales8.51
Price/Book14.29

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-0.19-0.08%
BMYBristol-Myers Squibb+0.19+0.35%
LLYEli Lilly and Co-0.03-0.04%
ABBVAbbVie+0.06+0.10%
Data as of 4:01pm ET, 02/21/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$1.63
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts